Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Oltipraz, an inhibitor of human immunodeficiency virus type 1 replication
Hans J. Prochaska
, Yong Yeh
, Penny Baron
, Bruce Polsky
Research output
:
Contribution to journal
›
Article
›
peer-review
71
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Oltipraz, an inhibitor of human immunodeficiency virus type 1 replication'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Human Immunodeficiency Virus Type 1 (HIV-1)
100%
Oltipraz
100%
1,2-Dithiole-3-thiones
37%
Inducer
25%
Glutathione
12%
Neoplasms
12%
Therapeutic Implications
12%
Ligand-binding Domain
12%
IC50
12%
Lymphoma Cells
12%
Methyl
12%
Infected Individual
12%
Glutathione Depletion
12%
Antiviral Activity
12%
Template-primer
12%
Clinical Evaluation
12%
Irreversible Inhibitor
12%
Basal Level
12%
Glutathione Reductase
12%
Reverse Transcriptase
12%
Phase II Enzymes
12%
Schistosomiasis
12%
Antiretroviral Activity
12%
Enzyme Induction
12%
Monofunctional
12%
Anticarcinogen
12%
Type 1 Agents
12%
3′-azido-3′-deoxythymidine
12%
Detoxication Enzymes
12%
Experimental Carcinogenesis
12%
Quinone Reductase
12%
Cutaneous T-cell Lymphoma
12%
Pharmacology, Toxicology and Pharmaceutical Science
Human Immunodeficiency Virus 1
100%
Oltipraz
100%
Glutathione
25%
1,2 Dithiole 3 Thione Derivative
25%
Neoplasm
12%
Clinical Trial
12%
Infection
12%
Antivirus Agent
12%
Anticarcinogen
12%
IC50
12%
Thymidine
12%
Schistosomiasis
12%
Cutaneous T Cell Lymphoma
12%
Detoxication
12%
Anti-Human Immunodeficiency Virus
12%
Enzymes
12%
Enzyme Induction
12%
Reduced Nicotinamide Adenine Dinucleotide (Phosphate) Dehydrogenase (Quinone)
12%
Glutathione Reductase
12%
Experimental Carcinogenesis
12%
Reverse Transcriptase
12%
Pathogenesis
12%